NUVL – nuvalent, inc. - class a (US:NASDAQ)

News

Nuvalent Appoints Ron Squarer to Board of Directors
Nuvalent, Inc. (NUVL) is a Buy On lung Cancer Treatment Prospects [Yahoo! Finance]
Does Nuvalent's Recent Trial Success Justify the Stock's 36% 2025 Rally? [Yahoo! Finance]
Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com